US Representative

Mariannette Miller-Meeks 2023-2024 Regular Session - Authored & Sponsored Legislation (Page 4)

Legislative Session

Co-Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1608

Introduced
3/14/23  
Refer
3/14/23  
Consumer and Fuel Retailer Choice Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1610

Introduced
3/14/23  
Refer
3/14/23  
Chiropractic Medicare Coverage Modernization Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1613

Introduced
3/17/23  
Refer
3/17/23  
Drug Price Transparency in Medicaid Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1634

Introduced
3/17/23  
Refer
3/17/23  
HELLPP Act Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1640

Introduced
3/17/23  
Refer
3/17/23  
Refer
3/24/23  
Report Pass
5/24/23  
Save Our Gas Stoves Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB167

Introduced
1/9/23  
Refer
1/9/23  
Patient Access to Urgent-Use Pharmacy Compounding Act of 2023 This bill relaxes certain requirements for compounding drugs that are facing shortages. Drug compounding is the process of mixing or otherwise altering drugs to create a medication. Currently, the Food and Drug Administration (FDA) allows for drug compounding subject to certain requirements. Generally, a licensed pharmacist or physician not registered with the FDA may only compound drugs in limited quantities for prescriptions for a specific individual patient. On the other hand, an FDA-registered outsourcing facility may compound drugs in bulk for use in medical facilities but is subject to additional requirements. This bill allows a compounder not registered with the FDA to compound drugs in limited quantities for an urgent medical need not involving a specific patient if, among other requirements (1) the prescriber certifies that the prescriber is unable, despite reasonable attempts, to obtain certain related drugs with the same active ingredient and route of administration; (2) the compounded drug meets certain labeling requirements, including an indication that the compounded drug is provided only for urgent administration to a patient; and (3) the compounder requests and maintains certain records about patients receiving the compounded drug. Furthermore, a restriction against an unregistered compounder regularly compounding (or compounding inordinate amounts of) what is essentially a copy of a commercially available drug shall not apply if the drug is on a shortage list maintained by the FDA or the American Society of Hospital Pharmacists.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1671

Introduced
3/21/23  
Refer
3/21/23  
Increasing Access to Dental Insurance Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1691

Introduced
3/22/23  
Refer
3/22/23  
Refer
3/31/23  
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1709

Introduced
3/22/23  
Refer
3/22/23  
Tribal Firearm Access Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1748

Introduced
3/23/23  
Quantum in Practice Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1756

Introduced
3/23/23  
Refer
3/23/23  
Dairy Pricing Opportunity Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1777

Introduced
3/24/23  
United States-Israel Future of Warfare Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1787

Introduced
3/24/23  
Carnivals are Real Entertainment Act

Primary Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1645

Introduced
3/17/23  
Refer
3/17/23  
Biochar Research Network Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB1790

Introduced
3/24/23  
Refer
3/24/23  
Biologics Competition Act of 2023